References
- Pettersson F, Björkholm E, Näslund I. Evaluation of screening for cervical cancer in Sweden: trends in incidence and mortality 1958–1980. Int J Epidemiol 1985; 14: 521–7.
- Nieminen P, Kallio M, Hakama M. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet Gynecol 1995; 85: 1017–21.
- Rylander E. [More effective screening prevents cervical cancer.] (in Swedish.) Läkartidningen 1996; 93: 345–8.
- Raffle A, Alden B, Mackenzie E. Detection rates for abnormal cervical smears: what are we screening for? Lancet 1995; 345: 1469–73.
- Mählck CG, Jonsson H, Lenner P. Pap smear screening and changes in cervical cancer mortality in Sweden. Int J Gynecol Obstet 1994; 44: 267–72.
- Reelick NF, de Haes WFM, Schurman JH. Psychological side-effects of mass screening on cervical cancer. Soc Sci Med 1984; 18: 1089–93.
- Beresford J, Gervaize P. The emotional impact on abnormal Pap smears on patients referred for colposcopy. Colposcopy Gynecol Laser Surg 1986; 2: 83–7.
- Lerman C, Miller S, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol 1991; 165: 658–62.
- Lauver D, Rubin M. Women’s concerns about abnormal Papanicolaou test results. J Obstet Gynaecol Neonatal Nurs 1991; 20: 154–9.
- Andersson-Ellström A, Seidal T, Grannas M, Hagmar B. The Pap-smear history of women with invasive cervical squamous carcinoma. Acta Obstet Gynecol Scand 2000; 79: 221–6.
- National Board of Health and Welfare, Stockholm, Sweden. Gynaecological Pap-smear control. A proposed screening program. Stockholm, Sweden: National Board of Health and Welfare, 1998: 15.
- Statistics Sweden. Educational level (2000-01-01) http:llwww.scb.selstatistik.
- Ideström M, Milsom I, Andersson-Ellström A. Knowledge and attitudes about the Pap-smear screening program: a population-based study of women aged 20–59 years. Acta Obstet Gynecol Scand 2002; 81: 962–7.
- Bergmark K, Avall Lundqvist E, Steineck G. Swedish study of women treated for cervical cancer: gynaecological cancer often affects sexuality. Lakartidningen 2000; 97: 5347–55.
- Rajaram S, Hill J, Rave C, Crabtree B. A biographical disruption: the case of an abnormal Pap smear. Health Care Women Int 1997; 18: 521–31.
- Wardle J, Pope R. The psychological costs of screening for cancer. J Psychosom Res 1992; 7: 609–24.
- Bell S, Porter M, Kitchener MD, Fraser C, Fisher P, Mann E. Psychological response to cervical screening. Prev Med 1995; 24: 610–16.
- Richardson PH, Doherty I, Wolfe CDA, Carman N, Chamberlain F, Holtom R et al. Evaluation of cognitive behavioural counselling for the distress associated with an abnormal cervical smear result. Br J Health Psychol 1996; 1: 327–38.
- Quilliam S. Emotional aspects of positive smears. Health Visitor 1989; 62: 308–9.
- Nugent L, Tamlyn-Leaman K, Nessim I, Reardon E, Crumley J. Anxiety and the colposcopy experience. Clin Nurs Res 1993; 2: 267–77.
- Wilkinson C, Jones JM, McBride J. Anxiety caused by abnormal result of cervical smear test: a controlled trial. Br Med J 1990; 300: 440.